Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization
N. Palanisamy, P. D. Arachchige, S. Carskadon, J. Li, I. Loveless, M. Alhamar, J. O. Peabody, H. Stricker, D. A. Chitale, C. G. Rogers, M. Menon, T. A. Bismar, N. S. Gupta, S. R. Williamson
The paper evaluates molecular heterogeneity in prostate cancer biopsy samples using dual immunohistochemistry and RNA in situ hybridization, finding clonal differences and higher heterogeneity in African American patients.
bioRxiv · Oct 25, 2019Cancer Biology